These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9786454)

  • 1. Inhibin and ovarian cancer.
    Burger HG; Baillie A; Drummond AE; Healy DL; Jobling T; Mamers P; Robertson DM; Susil B; Cahir N; Shen Y; Verity K; Fuller PJ; Groome NP; Findlay JK
    J Reprod Immunol; 1998 Aug; 39(1-2):77-87. PubMed ID: 9786454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibin and ovarian cancer].
    Burger HG; Baillie A; Drummond AE; Healy DL; Jobling T; Mamers P; Robertson DM; Susil B; Cahir N; Shen Y; Verity K; Fuller PJ; Groome NP; Findlay JK
    Vopr Onkol; 1999; 45(4):369-73. PubMed ID: 10532093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours.
    Burger HG; Robertson DM; Cahir N; Mamers P; Healy DL; Jobling T; Groome N
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):413-8. PubMed ID: 8706307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibin forms in serum from postmenopausal women with ovarian cancers.
    Robertson DM; Cahir N; Burger HG; Mamers P; Groome N
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):381-6. PubMed ID: 10435065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
    Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ
    N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
    Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG
    J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibins and ovarian cancer.
    Burger HG; Fuller PJ; Chu S; Mamers P; Drummond A; Susil B; Neva P; Robertson DM
    Mol Cell Endocrinol; 2001 Jun; 180(1-2):145-8. PubMed ID: 11451584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total inhibin is a potential serum marker for epithelial ovarian cancer.
    Tsigkou A; Marrelli D; Reis FM; Luisi S; Silva-Filho AL; Roviello F; Triginelli SA; Petraglia F
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of inhibin and activin subunits in human epithelial ovarian tumors.
    Yamashita K; Yamoto M; Shikone T; Minami S; Nakano R
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):316-22. PubMed ID: 9988793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
    Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
    Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibins/activins as diagnostic markers for ovarian cancer.
    Robertson DM; Stephenson T; Pruysers E; Burger HG; McCloud P; Tsigos A; Groome N; Mamers P; McNeilage J; Jobling T; Healy D
    Mol Cell Endocrinol; 2002 May; 191(1):97-103. PubMed ID: 12044923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadal malignant germ cell tumors express immunoreactive inhibin/activin subunits.
    Cobellis L; Cataldi P; Reis FM; De Palo G; Raspagliesi F; Pilotti S; Arcuri F; Petraglia F
    Eur J Endocrinol; 2001 Dec; 145(6):779-84. PubMed ID: 11720904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue.
    Gurusinghe CJ; Healy DL; Jobling T; Mamers P; Burger HG
    Gynecol Oncol; 1995 Apr; 57(1):27-32. PubMed ID: 7705698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
    Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
    Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin as a diagnostic marker for ovarian cancer.
    Robertson DM; Pruysers E; Jobling T
    Cancer Lett; 2007 Apr; 249(1):14-7. PubMed ID: 17320281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibin as a marker for ovarian cancer.
    Cooke I; O'Brien M; Charnock FM; Groome N; Ganesan TS
    Br J Cancer; 1995 May; 71(5):1046-50. PubMed ID: 7734297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibin secretion in the mare: localization of inhibin alpha, betaA, and betaB subunits in the ovary.
    Nagamine N; Nambo Y; Nagata S; Nagaoka K; Tsunoda N; Taniyama H; Tanaka Y; Tohei A; Watanabe G; Taya K
    Biol Reprod; 1998 Dec; 59(6):1392-8. PubMed ID: 9828183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer.
    Lambert-Messerlian GM; Steinhoff M; Zheng W; Canick JA; Gajewski WH; Seifer DB; Schneyer AL
    Gynecol Oncol; 1997 Jun; 65(3):512-6. PubMed ID: 9190984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women.
    Burger HG; Cahir N; Robertson DM; Groome NP; Dudley E; Green A; Dennerstein L
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):809-13. PubMed ID: 9713572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma.
    Menon U; Riley SC; Thomas J; Bose C; Dawnay A; Evans LW; Groome NP; Jacobs IJ
    BJOG; 2000 Sep; 107(9):1069-74. PubMed ID: 11002947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.